Cell Point (India) (NSE:CELLPOINT) Marketable Securities: ₹0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CELLPOINT Cell Point (India) Ltd NSE:CELLPOINT
74 GF Score
Price ₹15.80
GF Value ₹34.89
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Cell Point (India) Marketable Securities?

Cell Point (India) NSE:CELLPOINT 74 Marketable Securities is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:CELLPOINT with a GF Score™ of 74/100 and a GF Value™ of ₹34.89 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Cell Point (India)'s Marketable Securities for the quarter that ended in Mar. 2026 was ₹0 Mil.

Cell Point (India)  (NSE:CELLPOINT) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Cell Point (India) Marketable Securities Related Terms

Cell Point (India) Marketable Securities Historical Data

* Premium members only.

The historical data trend for Cell Point (India)'s Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Point (India) Marketable Securities Chart

Cell Point (India) Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Cell Point (India) Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:CELLPOINT
74GF Score
Cell Point (India) Ltd NSE:CELLPOINT
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cell Point (India) Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0 Mil mean?
Cell Point (India) (NSE:CELLPOINT) has a Marketable Securities of ₹0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Cell Point (India) and its competitors.
Is Cell Point (India)'s Marketable Securities too high?
Cell Point (India)'s current Marketable Securities is ₹0 Mil. Overall, Cell Point (India) has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cell Point (India)'s Marketable Securities compare to CASY and WSM?
Cell Point (India)'s Marketable Securities of ₹0 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Retail - Cyclical company?
A good Marketable Securities depends on the Retail - Cyclical industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Cell Point (India) and its competitors. Cell Point (India)'s current Marketable Securities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Point (India) stock overvalued right now?
Based on GuruFocus' analysis, Cell Point (India) (NSE:CELLPOINT) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹34.89, compared to a current price of ₹15.80 — trading 54.7% below its estimated fair value. The current Marketable Securities is ₹0 Mil. Cell Point (India)'s overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Cell Point (India) (NSE:CELLPOINT), the current Marketable Securities is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cell Point (India) (NSE:CELLPOINT) Overvalued in 2026?

Based on GuruFocus' analysis, Cell Point (India) stock appears to be undervalued. The current stock price of ₹15.80 is trading 54.7% below its estimated GF Value™ of ₹34.89. GuruFocus considers Cell Point (India) to be Significantly Undervalued.

Key valuation signals for NSE:CELLPOINT:

  • Marketable Securities: ₹0 Mil
  • GF Value™: ₹34.89 vs. price of ₹15.80 (54.7% below fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the NSE:CELLPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cell Point (India) Business Description

Address Lalitha Colony, Door No. 30-15-134, Dabagardens, Visakhapatnam, AP, IND, 530020
Cell Point (India) Ltd is engaged in multi-brand retail selling of smartphones, tablets, mobile accessories, and mobile-related products of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, etc. It is also engaged in retail selling of consumer durable electronics goods, smart televisions, smart watches, and air conditioners of various brands such as Xiaomi, Realme, and One Plus among others. The company operates in a single segment and derives revenue from its operations in India.
74GF Score

Get the complete analysis for NSE:CELLPOINT

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.80
Price
₹34.89
GF Value